• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 

New Search Back To Search Results
Recognition List Number: 009 FR Publication Date: 03/08/2004 

Part B: Supplementary Information

Recognition Number 7-86: NCCLS C29-A2, standardization of sodium and potassium ion selective electrode systems to the flame photometric reference method; approved standard (2000) isbn 1-56238-406-6. (InVitro Diagnostics)

Date of Standard: 2000. 
Address of Standards Development Organization:
 National Committee for Clinical Laboratory Standards (NCCLS)
  950 West Valley Road
  Suite 2500
  Wayne, PA 19087
 
CDRH Offices and Divisions associated with recognized standards:
(1)OFFICE OF IN VITRO DIAGNOSTICS AND RADIOLOGICAL HEALTH (OIR)
DIVISION OF CHEMISTRY AND TOXICOLOGY DEVICES (DCTD)
(2)OFFICE OF COMPLIANCE (OC)
Devices Affected:
In Vitro Diagnostic devices for the measurement of sodium and potassium using ion-selective electrodes system
Processes Affected:
510(K), PMA, PDP, IDE, HDE
Type of Standard:
 Horizontal, National
Extent of Recognition:
Complete standard
Related CFR Citations and Product Codes:
Regulation
Number
Device Name Device
Class
Product
Code
§862.1600 Electrode, Ion Specific, Potassium Class 2 CEM
§862.1665 Electrode, Ion Specific, Sodium Class 2 JGS
Relevant Guidance:
Points to Consider for Consider for Collection of Data in Support of In-Vitro Device Submissions for 510(k) Clearance Guidance for Industry In Vitro Diagnostic Potassium Test System Guidance for Industry In Vitro Diagnostic Sodium Test System.
FDA Technical Contact:
 Meshaun Payne
  FDA/CDRH/OIR
  10903 New Hampshire Avenue Building 66, Room 5650
  Silver Spring MD 20993
  301/796-6668
  email: meshaun.payne@fda.hhs.gov
-
-